Symptomtext
have a lingering upset stomach; having a little difficult with mobility,symptoms continued to get worse, was experiencing a complete loss of mobility; fever; vomiting; tiredness; condition aggravated; began to experience chills; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional. This case involves a 76 years old male patient who began to experience chills, have a lingering upset stomach, having a little difficult with mobility,symptoms continued to get worse, was experiencing a complete loss of mobility, fever, vomiting and tiredness after receiving vaccine Influenza Quadrival A-B High Dose HV Vaccine [Fluzone High-Dose Quadrivalent]. The patient's past medical history, vaccination(s) and family history were not provided. On 29-Sep-2022 around 10:00 am, the patient received a 0.7 ml (Milliliter) dose of suspect Influenza Quadrival A-B High Dose HV Vaccine (lot- UJ900AA, expiry date- unknown) via intramuscular route in the deltoid nos for immunization. On 29-Sep-2022 the patient began to experience chills (chills), having a little difficult with mobility, was experiencing a complete loss of mobility (mobility decreased) with condition aggravated, fever (pyrexia), vomiting, tiredness (Latency- same day) following the administration of Influenza Quadrival A-B High Dose HV Vaccine. On an unknown date the patient have a lingering upset stomach (abdominal discomfort) (unknown latency) following the administration of Influenza Quadrival A-B High Dose HV Vaccine. It was reported that "the patient was transported via ambulance to the emergency room (ER) of where he was seen and treated by. Patient stated that he was there for around 5 hours, and they "did every test under the sun," including a Covid test, an electrocardiogram, a chest X-ray. They gave him fluids, either glucose or saline, he was not sure which, and they monitored his blood pressure. He was told that if he regained his mobility, they would sign him out, but if he did not, they were going to admit him to the hospital. Around 5 am he had improved and regained his mobility, so he was released from the ER without being admitted to the hospital". Action taken: not applicable. The corrective treatment was unknown for other events and the patient was treated with PARACETAMOL (TYLENOL) for Fever, IBUPROFEN (ADVIL [IBUPROFEN]) for Fever and FAMOTIDINE (PEPCID [FAMOTIDINE]) for Upset stomach. At time of reporting, the outcome was Recovering / Resolving for the events and was Recovered / Resolved on 30-Sep-2022 for the event Mobility decreased.